- Oosagitta gen. nov. from tropical Africa, with revision of two species and description of four new species (Coleoptera: Chrysomelidae, Galerucinae) (2013)
- After our taxonomic revision of Ootheca Chevrolat, 1837, and the description of Oothecoides Kortenhaus & Wagner, 2011 and Ootibia Kortenhaus & Wagner, 2012, it became clear that a further four galerucine species, closely related to the above named taxa, form a distinct monophyletic group, that constitutes a new genus, Oosagitta gen. nov. with O. anningae sp. nov., O. geescheae sp. nov., O. melanopicta sp. nov. and O. thomasi sp. nov.. Exosoma angolensis Laboissière, 1939, the type species of the new genus, and Ergana minuta Laboissière, 1937 are newly transferred to Oosagitta gen. nov. All species of Oosagitta gen. nov. are characterized by a broad body and pronotum, a more or less convex dorsum and short legs, and as such are most similar to the other above named genera. The antennae of Oosagitta gen. nov. are distinctly longer than those of Ootheca, Oothecoides and Ootibia. Genital structures of the males allow a reliable identifi cation of the genus. (Re-) descriptions are given for all species, including semi-schematic illustrations depicting the habitus outline, shape of the basal antennomeres and the median lobe. Photographs of the name-bearing types and distribution maps are provided.
- Peroxisome Proliferator-Activated Receptor alpha (PPAR alpha) down-regulation in cystic fibrosis lymphocytes (2006)
- Background PPARs exhibit anti-inflammatory capacities and are potential modulators of the inflammatory response. We hypothesized that their expression and/or function may be altered in cystic fibrosis (CF), a disorder characterized by an excessive host inflammatory response. Methods PPARα, β and γ mRNA levels were measured in peripheral blood cells of CF patients and healthy subjects via RT-PCR. PPARα protein expression and subcellular localization was determined via western blot and immunofluorescence, respectively. The activity of PPARα was analyzed by gel shift assay. Results In lymphocytes, the expression of PPARα mRNA, but not of PPARβ, was reduced (-37%; p < 0.002) in CF patients compared with healthy persons and was therefore further analyzed. A similar reduction of PPARα was observed at protein level (-26%; p < 0.05). The transcription factor was mainly expressed in the cytosol of lymphocytes, with low expression in the nucleus. Moreover, DNA binding activity of the transcription factor was 36% less in lymphocytes of patients (p < 0.01). For PPARα and PPARβ mRNA expression in monocytes and neutrophils, no significant differences were observed between CF patients and healthy persons. In all cells, PPARγ mRNA levels were below the detection limit. Conclusion Lymphocytes are important regulators of the inflammatory response by releasing cytokines and antibodies. The diminished lymphocytic expression and activity of PPARα may therefore contribute to the inflammatory processes that are observed in CF.